{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001012","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-08-04T20:30:34+00:00","discovered_at":"2026-08-04T20:32:05.387939+00:00","generated_at":"2026-08-04T20:32:18.254545+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Splash Beverage enters development collaboration with Lupvindol for veterinary drug from CannEpil","bullets":["Lupvindol to lead FDA INAD and conditional approval for CannEpil-based veterinary product in companion-animal oncology and pain.","Milestone payments total up to $1.11M plus 4% royalty on net sales (or equity election) upon conditional approval or earlier licensing.","Splash provides milestone funding and commercial support; Lupvindol handles development and regulatory activities.","Initial term 5 years, auto-renew; Splash can terminate for convenience with 90 days notice and wind-down fee equal to next milestone.","Collaboration follows July 2026 exclusive license from Argent Biopharma (RGT) for CannEpil; royalty to RGT is 10% of net revenue for veterinary use."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001012","json":"https://secwatch.observer/filing/0001731122-26-001012.json","markdown":"https://secwatch.observer/filing/0001731122-26-001012.md","text":"https://secwatch.observer/filing/0001731122-26-001012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001012/0001731122-26-001012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001012/e7825_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:32:18.254545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}